Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The evidence for midlife women is growing A 2025 review in Current Opinion in Obstetrics and Gynecology concluded that GLP1 receptor agonists are among the most effective medications for weight loss and may be valuable for peri- and postmenopausal women, while noting that more population-specific data are needed
Become a member to get even more
F., Cueto, R
However, investors may be concerned about the company's likelihood of bringing this drug to market quickly enough to capture a sizable customer base, given that many alternatives are already available or are rushing through development
About the Expert Elizabeth Yurth, M.D., is the Chief Medical Officer of the Boulder Longevity Institute and a Hone-affiliated physician
US$ 21.42
US$ 20.94
US$ 23.93
